DEXMETHYLPHENIDATE HYDROCHLORIDE

DEXMETHYLPHENIDATE HYDROCHLORIDE was reported 3389 times

DEXMETHYLPHENIDATE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADULTERATED PRODUCT 14 0.1591
1 ARACHNOPHOBIA 1 0.1111
2 HAIR PLUCKING 2 0.1000
3 DISRUPTIVE MOOD DYSREGULATION DISORDER 3 0.0577
4 NAIL PICKING 2 0.0526
5 ALCALIGENES INFECTION 1 0.0500
6 ADRENOLEUKODYSTROPHY 1 0.0476
7 ACCESSORY CARDIAC PATHWAY 1 0.0455
8 ACQUIRED EPILEPTIC APHASIA 1 0.0417
9 AUDIOGRAM ABNORMAL 1 0.0312
10 SOMATIC SYMPTOM DISORDER 19 0.0222
11 INTELLIGENCE TEST ABNORMAL 2 0.0196
12 CLAUSTROPHOBIA 18 0.0195
13 ARCUS LIPOIDES 1 0.0192
14 SEXUAL ACTIVITY INCREASED 2 0.0180
15 TOURETTE'S DISORDER 4 0.0176
16 OPPOSITIONAL DEFIANT DISORDER 6 0.0172
17 CHANGE IN SUSTAINED ATTENTION 3 0.0151
18 AMINO ACID LEVEL ABNORMAL 1 0.0149
19 PRODUCT TAMPERING 15 0.0144
20 HAND-EYE COORDINATION IMPAIRED 2 0.0144
21 CAPSULE PHYSICAL ISSUE 2 0.0138
22 EDUCATIONAL PROBLEM 20 0.0131
23 ASPERGER'S DISORDER 1 0.0125
24 TIC 57 0.0121
25 DEFIANT BEHAVIOUR 2 0.0120
26 BONE DEVELOPMENT ABNORMAL 3 0.0119
27 ADRENAL CYST 1 0.0116
28 PRODUCT CONTAMINATION CHEMICAL 2 0.0115
29 ADHESIVE TAPE USE 2 0.0114
30 BODY HEIGHT INCREASED 3 0.0114
31 BACTERIA URINE 1 0.0104
32 ALKALOSIS HYPOCHLORAEMIC 1 0.0103
33 CROUP INFECTIOUS 6 0.0103
34 PULSE ABNORMAL 20 0.0103
35 AMPHETAMINES POSITIVE 6 0.0086
36 ANTISOCIAL PERSONALITY DISORDER 1 0.0086
37 AUTISM 8 0.0079
38 HYPERMETABOLISM 3 0.0078
39 BOREDOM 2 0.0070
40 GROWTH RETARDATION 17 0.0069
41 DERMATILLOMANIA 3 0.0065
42 RAYNAUD'S PHENOMENON 6 0.0064
43 DISTRACTIBILITY 6 0.0063
44 SOCIAL ANXIETY DISORDER 3 0.0063
45 DISTURBANCE IN SOCIAL BEHAVIOUR 13 0.0060
46 HYPERREFLEXIA 18 0.0059
47 CLUBBING 2 0.0058
48 NEGATIVISM 4 0.0057
49 BLUNTED AFFECT 3 0.0057
50 ANTISOCIAL BEHAVIOUR 5 0.0056
51 DRUG WITHDRAWAL HEADACHE 2 0.0056
52 ANOVULATORY CYCLE 1 0.0055
53 CATAPLEXY 7 0.0055
54 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0054
55 OCULAR NEOPLASM 2 0.0052
56 BELLIGERENCE 2 0.0050
57 ADMINISTRATION SITE ERYTHEMA 1 0.0049
58 IMPULSIVE BEHAVIOUR 15 0.0048
59 EXCESSIVE EYE BLINKING 6 0.0047
60 SYSTEMIC SCLERODERMA 2 0.0047
61 AUTISM SPECTRUM DISORDER 11 0.0045
62 GRIMACING 3 0.0044
63 OPIATES POSITIVE 2 0.0044
64 ABNORMAL BEHAVIOUR 153 0.0043
65 NEUROLOGICAL SYMPTOM 19 0.0042
66 HEAD BANGING 2 0.0042
67 ADMINISTRATION SITE BRUISE 1 0.0041
68 CATHETER SITE PRURITUS 3 0.0040
69 ADMINISTRATION SITE SWELLING 1 0.0039
70 TRICHOTILLOMANIA 2 0.0039
71 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 2 0.0038
72 PSYCHOMOTOR HYPERACTIVITY 55 0.0038
73 ASTHMA EXERCISE INDUCED 1 0.0037
74 ADENOIDECTOMY 1 0.0036
75 LEARNING DISORDER 4 0.0035
76 PSYCHOTIC BEHAVIOUR 3 0.0035
77 WEIGHT GAIN POOR 6 0.0034
78 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0034
79 PAINFUL ERECTION 2 0.0032
80 PSEUDOMONAS TEST POSITIVE 2 0.0031
81 PERFORMANCE STATUS DECREASED 12 0.0031
82 AGGRESSION 130 0.0030
83 VASOCONSTRICTION 2 0.0030
84 SOLILOQUY 2 0.0030
85 PRE-EXISTING CONDITION IMPROVED 17 0.0029
86 DISTURBANCE IN ATTENTION 133 0.0029
87 ANGER 85 0.0029
88 ALTERED VISUAL DEPTH PERCEPTION 2 0.0029
89 PARANOIA 42 0.0029
90 CARBON DIOXIDE INCREASED 3 0.0028
91 EYE ROLLING 2 0.0028
92 CLUSTER HEADACHE 3 0.0028
93 ENURESIS 9 0.0028
94 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0028
95 BEHAVIOUR DISORDER 9 0.0028
96 SIMPLE PARTIAL SEIZURES 2 0.0027
97 CEREBRAL PALSY 2 0.0027
98 DRUG EFFECT VARIABLE 3 0.0026
99 SELF INJURIOUS BEHAVIOUR 8 0.0026
100 UNDERWEIGHT 4 0.0026
101 NARCOLEPSY 4 0.0026
102 BRUGADA SYNDROME 2 0.0026
103 THERAPEUTIC RESPONSE CHANGED 7 0.0025
104 ABDOMINAL INJURY 1 0.0025
105 HALLUCINATIONS, MIXED 8 0.0025
106 CONVERSION DISORDER 4 0.0024
107 IMPULSE-CONTROL DISORDER 4 0.0024
108 FOAMING AT MOUTH 4 0.0024
109 ASYMPTOMATIC COVID-19 1 0.0024
110 SCREAMING 12 0.0023
111 TINEA INFECTION 2 0.0023
112 LOGORRHOEA 7 0.0023
113 SOCIAL AVOIDANT BEHAVIOUR 12 0.0023
114 SLEEP TERROR 7 0.0023
115 BANKRUPTCY 1 0.0023
116 BRAIN INJURY 18 0.0022
117 DEVICE POWER SOURCE ISSUE 3 0.0022
118 SUBSTANCE USE 2 0.0022
119 PRODUCT MEASURED POTENCY ISSUE 2 0.0022
120 DISINHIBITION 3 0.0021
121 AMBLYOPIA 1 0.0021
122 HOSTILITY 5 0.0021
123 NEGATIVE THOUGHTS 5 0.0021
124 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10 0.0021
125 ADRENAL ADENOMA 1 0.0020
126 ANGULAR CHEILITIS 1 0.0020
127 GLUCOSE URINE PRESENT 2 0.0020
128 BLADDER DISCOMFORT 2 0.0020
129 INTERCEPTED DRUG DISPENSING ERROR 3 0.0020
130 DRUG SCREEN NEGATIVE 3 0.0020
131 MOOD SWINGS 55 0.0020
132 CRYING 63 0.0020
133 DENTAL CARE 3 0.0020
134 ENERGY INCREASED 10 0.0020
135 DEVICE INFORMATION OUTPUT ISSUE 5 0.0019
136 DRUG TOLERANCE 8 0.0019
137 SUICIDAL BEHAVIOUR 7 0.0019
138 STARING 4 0.0019
139 HYPERTENSIVE CRISIS 18 0.0019
140 ATONIC SEIZURES 1 0.0019
141 DYSPHEMIA 7 0.0019
142 HOMICIDAL IDEATION 7 0.0019
143 IRRITABILITY 96 0.0019
144 PNEUMONIA STAPHYLOCOCCAL 3 0.0018
145 OCULOGYRIC CRISIS 3 0.0018
146 TERMINAL INSOMNIA 2 0.0018
147 EMOTIONAL DISORDER 48 0.0018
148 OBSESSIVE-COMPULSIVE DISORDER 13 0.0018
149 PRODUCT SUBSTITUTION ISSUE 89 0.0018
150 CATHETER SITE ERYTHEMA 3 0.0018
151 EXOPHTHALMOS 3 0.0018
152 PRODUCT PHYSICAL ISSUE 27 0.0018
153 AFFECTIVE DISORDER 11 0.0018
154 BIPOLAR DISORDER 17 0.0018
155 BACTERIAL VAGINOSIS 2 0.0018
156 ANXIETY DISORDER 5 0.0018
157 AMINO ACID LEVEL INCREASED 1 0.0018
158 ABNORMAL SLEEP-RELATED EVENT 2 0.0017
159 GENERALISED ANXIETY DISORDER 2 0.0017
160 ERECTION INCREASED 7 0.0017
161 APPLICATION SITE INFLAMMATION 2 0.0017
162 GYNAECOMASTIA 50 0.0017
163 PRIAPISM 5 0.0017
164 EXPIRED DEVICE USED 3 0.0017
165 PRODUCT COLOUR ISSUE 6 0.0017
166 BRAIN FOG 2 0.0017
167 HYPERPHAGIA 5 0.0017
168 DARK CIRCLES UNDER EYES 2 0.0016
169 MYDRIASIS 17 0.0016
170 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
171 THROAT CLEARING 4 0.0016
172 INITIAL INSOMNIA 12 0.0016
173 DAYDREAMING 2 0.0015
174 DRUG DIVERSION 5 0.0015
175 BLEPHAROSPASM 6 0.0015
176 CATHETER SITE HAEMORRHAGE 3 0.0015
177 DEAFNESS BILATERAL 2 0.0015
178 TONSILLECTOMY 2 0.0015
179 CYSTITIS INTERSTITIAL 2 0.0015
180 ALLERGIC REACTION TO EXCIPIENT 2 0.0015
181 ILLUSION 2 0.0015
182 FORMICATION 9 0.0015
183 ROTATOR CUFF REPAIR 2 0.0015
184 COSTOCHONDRITIS 2 0.0015
185 PHARYNGITIS STREPTOCOCCAL 12 0.0014
186 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0014
187 MOOD ALTERED 32 0.0014
188 VIOLENCE-RELATED SYMPTOM 2 0.0014
189 ALLERGY TO ANIMAL 1 0.0014
190 PSYCHOTIC SYMPTOM 2 0.0014
191 SOMNAMBULISM 8 0.0014
192 INAPPROPRIATE AFFECT 2 0.0014
193 RED BLOOD CELL COUNT INCREASED 3 0.0014
194 WITHDRAWAL SYNDROME 44 0.0014
195 BREAST ENLARGEMENT 4 0.0014
196 BLADDER SPASM 2 0.0014
197 PERSONALITY DISORDER 3 0.0013
198 AMENORRHOEA 19 0.0013
199 MUSCLE TWITCHING 26 0.0013
200 PERSONALITY CHANGE 11 0.0013
201 YAWNING 3 0.0013
202 CRANIOCEREBRAL INJURY 3 0.0013
203 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0013
204 SNORING 4 0.0013
205 CLUMSINESS 3 0.0013
206 INABILITY TO AFFORD MEDICATION 7 0.0013
207 HYPERAEMIA 2 0.0013
208 PRODUCT LOT NUMBER ISSUE 2 0.0013
209 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
210 OBSESSIVE THOUGHTS 2 0.0013
211 BLOOD PROLACTIN INCREASED 5 0.0012
212 STRABISMUS 3 0.0012
213 BLOOD CREATININE DECREASED 3 0.0012
214 DEREALISATION 2 0.0012
215 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0012
216 SUICIDAL IDEATION 91 0.0012
217 EXCORIATION 3 0.0012
218 DRUG DISPENSING ERROR 18 0.0012
219 DECREASED INTEREST 6 0.0012
220 SELF-INJURIOUS IDEATION 4 0.0012
221 TONGUE BITING 2 0.0012
222 LIVER INJURY 18 0.0012
223 HALLUCINATION, AUDITORY 15 0.0012
224 INCORRECT STORAGE OF DRUG 2 0.0012
225 FEELING JITTERY 19 0.0012
226 INSURANCE ISSUE 7 0.0011
227 DRUG PRESCRIBING ERROR 22 0.0011
228 WRONG PRODUCT ADMINISTERED 5 0.0011
229 DRUG ADMINISTERED AT INAPPROPRIATE SITE 12 0.0011
230 PRODUCT AVAILABILITY ISSUE 13 0.0011
231 BRUXISM 5 0.0011
232 UPPER-AIRWAY COUGH SYNDROME 7 0.0011
233 ASTERIXIS 1 0.0011
234 PRESCRIBED OVERDOSE 17 0.0011
235 ARTERIAL HAEMORRHAGE 1 0.0011
236 STAPHYLOCOCCUS TEST POSITIVE 2 0.0011
237 ACCIDENT AT WORK 2 0.0011
238 OTITIS MEDIA 3 0.0011
239 TEARFULNESS 4 0.0011
240 COMPULSIVE SHOPPING 2 0.0011
241 ACARODERMATITIS 1 0.0011
242 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39 0.0011
243 PARADOXICAL DRUG REACTION 3 0.0011
244 EYE MOVEMENT DISORDER 6 0.0011
245 PSYCHOTIC DISORDER 26 0.0011
246 CYSTIC FIBROSIS 5 0.0011
247 RETCHING 18 0.0011
248 CATHETER SITE PAIN 2 0.0011
249 DEPRESSION SUICIDAL 3 0.0010
250 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0010
251 AGITATION 64 0.0010
252 HYPOPHAGIA 20 0.0010
253 PRODUCT SIZE ISSUE 4 0.0010
254 ADJUSTMENT DISORDER 1 0.0010
255 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0010
256 BREATH ODOUR 2 0.0010
257 SLEEP APNOEA SYNDROME 16 0.0010
258 PETIT MAL EPILEPSY 4 0.0010
259 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
260 ANKLE OPERATION 1 0.0010
261 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 4 0.0010
262 HYPOMANIA 3 0.0010
263 AFFECT LABILITY 8 0.0009
264 OEDEMA MOUTH 3 0.0009
265 COMMUNICATION DISORDER 3 0.0009
266 SKIN WRINKLING 2 0.0009
267 ESSENTIAL HYPERTENSION 2 0.0009
268 APPLICATION SITE IRRITATION 10 0.0009
269 DEPRESSED MOOD 39 0.0009
270 SOCIAL PROBLEM 3 0.0009
271 BILIARY COLIC 2 0.0009
272 OVERWEIGHT 4 0.0009
273 HALLUCINATION, VISUAL 15 0.0009
274 COELIAC DISEASE 7 0.0009
275 FINE MOTOR SKILL DYSFUNCTION 2 0.0009
276 TARDIVE DYSKINESIA 24 0.0009
277 PRODUCT FORMULATION ISSUE 5 0.0009
278 OBESITY 11 0.0009
279 SELF ESTEEM DECREASED 2 0.0009
280 DRUG LEVEL DECREASED 7 0.0009
281 HYPERPROLACTINAEMIA 5 0.0009
282 REBOUND EFFECT 6 0.0009
283 MICTURITION URGENCY 8 0.0009
284 FEAR 21 0.0009
285 MAJOR DEPRESSION 5 0.0009
286 TRICHORRHEXIS 2 0.0009
287 VENTRICULAR HYPERTROPHY 2 0.0009
288 HALLUCINATION 50 0.0009
289 ABNORMAL WEIGHT GAIN 10 0.0008
290 EATING DISORDER 15 0.0008
291 RECALLED PRODUCT ADMINISTERED 4 0.0008
292 FOOD ALLERGY 4 0.0008
293 APPARENT DEATH 3 0.0008
294 GALACTORRHOEA 5 0.0008
295 DRUG EFFECT LESS THAN EXPECTED 4 0.0008
296 CENTRAL VENOUS CATHETERISATION 2 0.0008
297 FRUSTRATION TOLERANCE DECREASED 5 0.0008
298 PANIC REACTION 5 0.0008
299 APPETITE DISORDER 4 0.0008
300 INCREASED APPETITE 11 0.0008
301 CONCUSSION 5 0.0008
302 APPLICATION SITE PRURITUS 16 0.0008
303 CONVULSION 46 0.0008
304 PRODUCT QUALITY ISSUE 97 0.0008
305 MANIA 11 0.0008
306 ILLNESS 39 0.0008
307 APPLICATION SITE HAEMORRHAGE 2 0.0008
308 PARKINSON'S DISEASE 2 0.0008
309 POTENTIATING DRUG INTERACTION 2 0.0008
310 RESTLESSNESS 24 0.0008
311 DIABETIC COMA 2 0.0008
312 TONGUE DISORDER 5 0.0008
313 TENSION 4 0.0008
314 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0008
315 SCOLIOSIS 4 0.0008
316 DYSTONIA 13 0.0008
317 APPLICATION SITE ERYTHEMA 18 0.0008
318 GRAND MAL CONVULSION 7 0.0008
319 CYANOSIS 10 0.0008
320 VULVOVAGINAL DRYNESS 2 0.0008
321 CREPITATIONS 2 0.0007
322 SUPRAVENTRICULAR TACHYCARDIA 6 0.0007
323 DECREASED APPETITE 133 0.0007
324 THINKING ABNORMAL 12 0.0007
325 SUSPECTED COUNTERFEIT PRODUCT 2 0.0007
326 PENILE PAIN 2 0.0007
327 STREPTOCOCCAL INFECTION 3 0.0007
328 TRISMUS 3 0.0007
329 DYSKINESIA 24 0.0007
330 FEELING ABNORMAL 146 0.0007
331 GENERALISED ERYTHEMA 4 0.0007
332 VISUAL DISTURBANCE 4 0.0007
333 AMYLASE INCREASED 2 0.0007
334 BLOOD PHOSPHORUS DECREASED 2 0.0007
335 NON-CARDIAC CHEST PAIN 2 0.0007
336 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0007
337 TACHYPHRENIA 2 0.0007
338 COLD SWEAT 10 0.0007
339 EUPHORIC MOOD 6 0.0007
340 ACUTE SINUSITIS 1 0.0007
341 AUTOIMMUNE DISORDER 4 0.0007
342 PRODUCT USE COMPLAINT 6 0.0007
343 AURA 1 0.0007
344 DRUG EFFECT DELAYED 3 0.0007
345 HANGOVER 2 0.0007
346 SEDATION 13 0.0007
347 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0007
348 HYPERACUSIS 2 0.0007
349 GLUCOSE TOLERANCE IMPAIRED 3 0.0006
350 DRUG EFFECT DECREASED 35 0.0006
351 APPLICATION SITE DISCOMFORT 1 0.0006
352 TYPE 1 DIABETES MELLITUS 3 0.0006
353 LETHARGY 31 0.0006
354 DEPRESSION 125 0.0006
355 DRUG EFFECT INCREASED 2 0.0006
356 ANXIETY 151 0.0006
357 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0006
358 ANGIOPATHY 3 0.0006
359 METABOLIC DISORDER 3 0.0006
360 PERIPHERAL COLDNESS 7 0.0006
361 MEDICATION ERROR 28 0.0006
362 NIGHTMARE 18 0.0006
363 CHOLECYSTITIS CHRONIC 4 0.0006
364 PRODUCT PACKAGING QUANTITY ISSUE 4 0.0006
365 PALPITATIONS 58 0.0006
366 PANIC DISORDER 2 0.0006
367 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
368 SOMNOLENCE 99 0.0006
369 DRUG SCREEN POSITIVE 4 0.0006
370 PANIC ATTACK 18 0.0006
371 ARTERIAL THROMBOSIS 1 0.0006
372 APATHY 7 0.0006
373 ELECTROCARDIOGRAM ABNORMAL 4 0.0006
374 APNOEA 4 0.0006
375 NERVOUSNESS 27 0.0006
376 INFUSION SITE EXTRAVASATION 3 0.0006
377 GASTROENTERITIS VIRAL 8 0.0006
378 HEART RATE INCREASED 46 0.0006
379 INCONTINENCE 5 0.0006
380 DROOLING 3 0.0006
381 FRUSTRATION 2 0.0006
382 RESPIRATORY RATE INCREASED 4 0.0006
383 DRUG INEFFECTIVE 588 0.0006
384 DRUG ADMINISTRATION ERROR 17 0.0006
385 THIRST 8 0.0006
386 MIDDLE INSOMNIA 8 0.0005
387 NECK PAIN 25 0.0005
388 MENTAL IMPAIRMENT 11 0.0005
389 BREAST MASS 3 0.0005
390 POOR VENOUS ACCESS 4 0.0005
391 APPLICATION SITE DISCOLOURATION 2 0.0005
392 DYSGRAPHIA 3 0.0005
393 NERVE COMPRESSION 4 0.0005
394 AKATHISIA 6 0.0005
395 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0005
396 CEREBRAL DISORDER 3 0.0005
397 THERAPY NON-RESPONDER 16 0.0005
398 INSOMNIA 117 0.0005
399 SWELLING FACE 28 0.0005
400 EAR DISORDER 2 0.0005
401 PRODUCT SOLUBILITY ABNORMAL 2 0.0005
402 FEEDING DISORDER 7 0.0005
403 MUSCLE RIGIDITY 5 0.0005
404 NO ADVERSE EVENT 61 0.0005
405 FOREIGN BODY 2 0.0005
406 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0005
407 WEIGHT INCREASED 91 0.0005
408 APPLICATION SITE SCAB 1 0.0005
409 ADVERSE DRUG REACTION 33 0.0005
410 THERAPEUTIC RESPONSE SHORTENED 8 0.0005
411 MULTIPLE ALLERGIES 3 0.0005
412 APPENDICITIS PERFORATED 1 0.0005
413 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
414 DRUG DOSE OMISSION BY DEVICE 11 0.0005
415 IMPAIRED GASTRIC EMPTYING 3 0.0005
416 PSYCHIATRIC SYMPTOM 3 0.0005
417 HYPERHIDROSIS 53 0.0005
418 FEELING HOT 25 0.0005
419 DYSPHAGIA 36 0.0005
420 DRY MOUTH 31 0.0005
421 WHEEZING 21 0.0005
422 INTENTIONAL SELF-INJURY 8 0.0005
423 POOR QUALITY DEVICE USED 3 0.0005
424 APLASTIC ANAEMIA 2 0.0005
425 FEELING DRUNK 3 0.0005
426 BODY TEMPERATURE DECREASED 4 0.0005
427 PRODUCT TASTE ABNORMAL 5 0.0005
428 VEIN DISORDER 2 0.0005
429 HEART RATE ABNORMAL 2 0.0005
430 HUNGER 4 0.0005
431 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0005
432 PRODUCT COMPLAINT 7 0.0005
433 UNEVALUABLE EVENT 30 0.0005
434 OSTEOPENIA 6 0.0005
435 TACHYCARDIA 33 0.0005
436 INTENTIONAL PRODUCT MISUSE 32 0.0005
437 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 68 0.0005
438 ATYPICAL PNEUMONIA 1 0.0005
439 DIABETIC NEUROPATHY 2 0.0005
440 PRODUCT SUPPLY ISSUE 2 0.0005
441 ACTINIC KERATOSIS 1 0.0005
442 URINARY INCONTINENCE 11 0.0004
443 POLYURIA 3 0.0004
444 MOVEMENT DISORDER 12 0.0004
445 PRODUCT PRESCRIBING ERROR 7 0.0004
446 FIBROMYALGIA 8 0.0004
447 APHTHOUS STOMATITIS 1 0.0004
448 LOSS OF CONSCIOUSNESS 46 0.0004
449 PRODUCT DISPENSING ERROR 6 0.0004
450 INTENTIONAL DOSE OMISSION 5 0.0004
451 PERIPHERAL VASCULAR DISORDER 2 0.0004
452 ABDOMINAL PAIN UPPER 70 0.0004
453 SCHIZOPHRENIA 4 0.0004
454 SKIN WARM 2 0.0004
455 MENTAL DISORDER 15 0.0004
456 MIGRAINE 31 0.0004
457 SKIN HYPERPIGMENTATION 3 0.0004
458 ALCOHOL ABUSE 1 0.0004
459 NO THERAPEUTIC RESPONSE 5 0.0004
460 BRONCHIECTASIS 2 0.0004
461 JAW DISORDER 2 0.0004
462 SPINAL OSTEOARTHRITIS 3 0.0004
463 COORDINATION ABNORMAL 5 0.0004
464 HYPERVENTILATION 2 0.0004
465 EAR INFECTION 8 0.0004
466 NASAL DRYNESS 2 0.0004
467 DEVICE BREAKAGE 9 0.0004
468 SLEEP DISORDER 21 0.0004
469 PRODUCT LABEL ISSUE 2 0.0004
470 PRODUCT ODOUR ABNORMAL 3 0.0004
471 ACNE CYSTIC 1 0.0004
472 HYPERSOMNIA 9 0.0004
473 ANKLE FRACTURE 5 0.0004
474 ANOREXIA 5 0.0004
475 STOMACH DISCOMFORT 2 0.0004
476 TREMOR 54 0.0004
477 SKIN LACERATION 3 0.0004
478 GRANULOCYTOPENIA 2 0.0004
479 BLOOD PRESSURE INCREASED 48 0.0004
480 POLLAKIURIA 13 0.0004
481 UNRESPONSIVE TO STIMULI 8 0.0004
482 EAR PAIN 6 0.0004
483 VITAMIN D DEFICIENCY 3 0.0004
484 ANGIONEUROTIC OEDEMA 1 0.0004
485 CHEST PAIN 58 0.0004
486 PRODUCT ADHESION ISSUE 10 0.0004
487 HEAD DISCOMFORT 5 0.0004
488 STEVENS-JOHNSON SYNDROME 7 0.0004
489 DRY THROAT 3 0.0004
490 PRESYNCOPE 7 0.0004
491 JOINT DISLOCATION 3 0.0004
492 ROAD TRAFFIC ACCIDENT 12 0.0004
493 SEIZURE 30 0.0004
494 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0004
495 DYSARTHRIA 11 0.0003
496 SINUSITIS 29 0.0003
497 EMOTIONAL DISTRESS 39 0.0003
498 WEIGHT DECREASED 79 0.0003
499 JOINT INJURY 6 0.0003
500 PRODUCT DOSE OMISSION 23 0.0003
501 SEROTONIN SYNDROME 5 0.0003
502 PALLOR 8 0.0003
503 BODY TEMPERATURE INCREASED 6 0.0003
504 HAND FRACTURE 2 0.0003
505 APPLICATION SITE DRYNESS 1 0.0003
506 MEMORY IMPAIRMENT 39 0.0003
507 SKIN DISCOLOURATION 13 0.0003
508 CONFUSIONAL STATE 46 0.0003
509 SPEECH DISORDER 15 0.0003
510 SUICIDE ATTEMPT 17 0.0003
511 DERMATITIS CONTACT 3 0.0003
512 ABDOMINAL DISTENSION 28 0.0003
513 INFUSION SITE PAIN 3 0.0003
514 PRODUCT DOSE OMISSION ISSUE 48 0.0003
515 VISION BLURRED 37 0.0003
516 ECONOMIC PROBLEM 5 0.0003
517 DRUG INTOLERANCE 25 0.0003
518 WRONG DRUG ADMINISTERED 3 0.0003
519 BLINDNESS TRANSIENT 2 0.0003
520 MUSCULAR WEAKNESS 31 0.0003
521 RASH MACULAR 9 0.0003
522 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
523 EXTRASYSTOLES 2 0.0003
524 DELUSION 4 0.0003
525 IMMUNOSUPPRESSION 2 0.0003
526 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0003
527 NAIL DISORDER 2 0.0003
528 ORAL PAIN 6 0.0003
529 VENTRICULAR FIBRILLATION 3 0.0003
530 MACULAR DEGENERATION 3 0.0003
531 LIPASE INCREASED 2 0.0003
532 CONDITION AGGRAVATED 70 0.0003
533 PSEUDOMONAS INFECTION 2 0.0003
534 ABDOMINAL DISCOMFORT 41 0.0003
535 VOMITING 116 0.0003
536 ABNORMAL FAECES 2 0.0003
537 POOR QUALITY DRUG ADMINISTERED 2 0.0003
538 PRODUCT ADMINISTRATION ERROR 4 0.0003
539 EXTRAPYRAMIDAL DISORDER 7 0.0003
540 WRIST FRACTURE 3 0.0003
541 EXTRA DOSE ADMINISTERED 7 0.0003
542 POOR QUALITY SLEEP 5 0.0003
543 HYPERCHOLESTEROLAEMIA 2 0.0003
544 GLOSSODYNIA 5 0.0003
545 SEASONAL ALLERGY 3 0.0003
546 HYSTERECTOMY 2 0.0003
547 ACCIDENTAL UNDERDOSE 2 0.0003
548 CYST 3 0.0003
549 HEADACHE 152 0.0003
550 MUSCLE TIGHTNESS 4 0.0003
551 TREATMENT FAILURE 18 0.0003
552 KNEE OPERATION 2 0.0003
553 CROHN'S DISEASE 2 0.0003
554 MENSTRUAL DISORDER 2 0.0003
555 ALCOHOL USE 1 0.0003
556 COMPLICATION OF DEVICE REMOVAL 3 0.0003
557 DIPLOPIA 6 0.0003
558 ABDOMINAL ABSCESS 1 0.0003
559 SCRATCH 2 0.0003
560 HYPERSENSITIVITY 43 0.0003
561 HYPOTHYROIDISM 7 0.0003
562 EYELID OEDEMA 3 0.0003
563 DYSMENORRHOEA 3 0.0003
564 HYPOAESTHESIA 35 0.0003
565 PRODUCT PACKAGING ISSUE 2 0.0003
566 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0003
567 HEMIPLEGIA 2 0.0003
568 THERAPY CESSATION 11 0.0003
569 NEPHROLITHIASIS 10 0.0003
570 VITAMIN D DECREASED 2 0.0003
571 SCAR 4 0.0003
572 PARAESTHESIA 37 0.0003
573 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0003
574 HEAD INJURY 7 0.0003
575 ROTATOR CUFF SYNDROME 3 0.0003
576 MUSCLE SPASTICITY 3 0.0003
577 BLOOD CALCIUM INCREASED 2 0.0003
578 QUALITY OF LIFE DECREASED 3 0.0003
579 APPLICATION SITE EXFOLIATION 1 0.0003
580 RETINAL DETACHMENT 2 0.0003
581 DERMATITIS ATOPIC 4 0.0003
582 MUSCLE SPASMS 41 0.0003
583 SPUTUM DISCOLOURED 2 0.0003
584 AMNESIA 15 0.0003
585 INTERVERTEBRAL DISC PROTRUSION 5 0.0003
586 PURPURA 2 0.0003
587 DEVELOPMENTAL DELAY 2 0.0003
588 BLOOD PRESSURE ABNORMAL 4 0.0003
589 SURGERY 11 0.0003
590 APPLICATION SITE PAIN 5 0.0003
591 SYRINGE ISSUE 3 0.0003
592 URTICARIA 34 0.0003
593 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
594 SKIN FISSURES 3 0.0003
595 FLANK PAIN 2 0.0003
596 IRRITABLE BOWEL SYNDROME 4 0.0003
597 DIZZINESS 105 0.0003
598 HYPERTENSION 44 0.0003
599 LUNG INFECTION 4 0.0003
600 ILL-DEFINED DISORDER 9 0.0003
601 DEPENDENCE 2 0.0003
602 SPINAL OPERATION 2 0.0003
603 MENORRHAGIA 5 0.0003
604 WEIGHT FLUCTUATION 2 0.0003
605 DRUG DOSE OMISSION 42 0.0003
606 PRODUCT PREPARATION ERROR 3 0.0003
607 ACCIDENTAL OVERDOSE 7 0.0003
608 INCREASED TENDENCY TO BRUISE 2 0.0003
609 BACK INJURY 2 0.0003
610 SALIVARY HYPERSECRETION 2 0.0002
611 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
612 ANAL ABSCESS 1 0.0002
613 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
614 HYPOKINESIA 3 0.0002
615 ABNORMAL DREAMS 6 0.0002
616 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
617 MOTOR DYSFUNCTION 2 0.0002
618 NAUSEA 154 0.0002
619 HYPOTHERMIA 2 0.0002
620 ACCIDENTAL EXPOSURE 1 0.0002
621 INFLUENZA 20 0.0002
622 INTENTIONAL DRUG MISUSE 5 0.0002
623 DEFORMITY 2 0.0002
624 BRONCHITIS 15 0.0002
625 SLUGGISHNESS 2 0.0002
626 VIRAL INFECTION 6 0.0002
627 NEUTROPHIL COUNT INCREASED 2 0.0002
628 HYPOTONIA 2 0.0002
629 DISORIENTATION 8 0.0002
630 MALAISE 86 0.0002
631 PETECHIAE 2 0.0002
632 UPPER LIMB FRACTURE 4 0.0002
633 RASH GENERALISED 6 0.0002
634 PRURITUS GENERALISED 5 0.0002
635 COUGH 50 0.0002
636 SWOLLEN TONGUE 6 0.0002
637 VISUAL ACUITY REDUCED 7 0.0002
638 APPLICATION SITE BURN 1 0.0002
639 FISTULA 2 0.0002
640 FOOT DEFORMITY 2 0.0002
641 TREATMENT NONCOMPLIANCE 9 0.0002
642 PRODUCT USE ISSUE 32 0.0002
643 OFF LABEL USE 130 0.0002
644 INJECTION SITE URTICARIA 4 0.0002
645 DRUG LEVEL INCREASED 3 0.0002
646 NEOPLASM 2 0.0002
647 PAIN OF SKIN 5 0.0002
648 CHOLECYSTECTOMY 2 0.0002
649 DRY EYE 7 0.0002
650 INCORRECT DOSE ADMINISTERED 33 0.0002
651 BLINDNESS 7 0.0002
652 BREAST PAIN 2 0.0002
653 FEELING COLD 5 0.0002
654 FATIGUE 133 0.0002
655 SEXUAL DYSFUNCTION 2 0.0002
656 ACCIDENT 2 0.0002
657 HAEMOPTYSIS 5 0.0002
658 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0002
659 SPINAL PAIN 2 0.0002
660 LACERATION 2 0.0002
661 COGNITIVE DISORDER 8 0.0002
662 DISEASE RECURRENCE 7 0.0002
663 NASOPHARYNGITIS 30 0.0002
664 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
665 NEURALGIA 4 0.0002
666 ERYTHEMA 35 0.0002
667 INJURY 13 0.0002
668 IMPAIRED DRIVING ABILITY 2 0.0002
669 CHOLECYSTITIS 2 0.0002
670 APHAGIA 1 0.0002
671 ECZEMA 5 0.0002
672 LYMPHOCYTE COUNT DECREASED 3 0.0002
673 IMPAIRED QUALITY OF LIFE 2 0.0002
674 HEART RATE DECREASED 6 0.0002
675 BLOOD UREA INCREASED 3 0.0002
676 DIABETIC KETOACIDOSIS 4 0.0002
677 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
678 PRODUCT DOSE OMISSION IN ERROR 2 0.0002
679 OSTEOPOROSIS 7 0.0002
680 HEART RATE IRREGULAR 4 0.0002
681 VISUAL IMPAIRMENT 19 0.0002
682 ASTHMA 16 0.0002
683 LIMB DISCOMFORT 5 0.0002
684 HERNIA 3 0.0002
685 PHARYNGEAL OEDEMA 3 0.0002
686 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0002
687 ACNE 13 0.0002
688 RESTLESS LEGS SYNDROME 3 0.0002
689 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
690 CHOKING 3 0.0002
691 GALLBLADDER DISORDER 3 0.0002
692 DEVICE ADHESION ISSUE 2 0.0002
693 DYSURIA 6 0.0002
694 ANAPHYLACTIC REACTION 8 0.0002
695 CONTUSION 15 0.0002
696 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
697 DRUG EFFECT INCOMPLETE 7 0.0002
698 PHARYNGITIS 2 0.0002
699 LIBIDO DECREASED 2 0.0002
700 IMMUNE SYSTEM DISORDER 2 0.0002
701 SKIN EXFOLIATION 12 0.0002
702 DRUG WITHDRAWAL SYNDROME 16 0.0002
703 NODULE 2 0.0002
704 TENDON RUPTURE 2 0.0002
705 DISABILITY 3 0.0002
706 FOOT FRACTURE 3 0.0002
707 BLOOD CHOLESTEROL INCREASED 7 0.0002
708 SINUS DISORDER 3 0.0002
709 EXPIRED PRODUCT ADMINISTERED 5 0.0002
710 FUNGAL INFECTION 5 0.0002
711 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0002
712 BEDRIDDEN 2 0.0002
713 LIP SWELLING 5 0.0002
714 MUSCULOSKELETAL DISORDER 3 0.0002
715 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
716 GAIT INABILITY 4 0.0002
717 NERVOUS SYSTEM DISORDER 5 0.0002
718 ABNORMAL LOSS OF WEIGHT 1 0.0002
719 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0002
720 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0002
721 SINUS CONGESTION 2 0.0002
722 SYNCOPE 15 0.0002
723 DEVICE ISSUE 11 0.0002
724 EPISTAXIS 11 0.0002
725 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0002
726 ASTHENIA 54 0.0002
727 DRY SKIN 17 0.0002
728 RESPIRATORY DISTRESS 4 0.0002
729 HAEMATOCRIT DECREASED 3 0.0002
730 INJECTION SITE EXTRAVASATION 2 0.0002
731 DYSPHONIA 8 0.0002
732 UNDERDOSE 10 0.0002
733 MASS 2 0.0002
734 EPILEPSY 4 0.0002
735 ARTHROPOD BITE 1 0.0002
736 TOXICITY TO VARIOUS AGENTS 22 0.0002
737 DYSPNOEA 77 0.0002
738 PARALYSIS 2 0.0002
739 BLOOD PRESSURE DECREASED 9 0.0002
740 RESPIRATORY DISORDER 4 0.0002
741 INJECTION SITE BRUISING 10 0.0002
742 ANHEDONIA 4 0.0002
743 NEUTROPHIL COUNT DECREASED 5 0.0002
744 CONSTIPATION 27 0.0002
745 IMPAIRED WORK ABILITY 3 0.0002
746 THYROID DISORDER 2 0.0002
747 NEEDLE ISSUE 3 0.0002
748 APPLICATION SITE RASH 2 0.0002
749 CARDIOMYOPATHY 2 0.0002
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0002
751 RHINORRHOEA 8 0.0002
752 HYPOAESTHESIA ORAL 2 0.0002
753 NIGHT SWEATS 4 0.0002
754 RASH 54 0.0002
755 TOOTH DISORDER 3 0.0002
756 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0002
757 CHROMATURIA 3 0.0002
758 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0002
759 BRADYCARDIA 7 0.0002
760 ASPHYXIA 1 0.0002
761 WHITE BLOOD CELL COUNT INCREASED 5 0.0002
762 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0002
763 SKIN IRRITATION 6 0.0002
764 INCORRECT PRODUCT STORAGE 2 0.0002
765 SKIN BURNING SENSATION 9 0.0002
766 APPLICATION SITE REACTION 1 0.0002
767 DEVICE RELATED INFECTION 2 0.0002
768 BONE LOSS 2 0.0001
769 BACK DISORDER 2 0.0001
770 GASTROINTESTINAL DISORDER 9 0.0001
771 PYREXIA 42 0.0001
772 OROPHARYNGEAL PAIN 11 0.0001
773 CHEST DISCOMFORT 12 0.0001
774 PAIN 76 0.0001
775 DRUG TOXICITY 2 0.0001
776 STOMATITIS 7 0.0001
777 BLOOD PRESSURE FLUCTUATION 3 0.0001
778 OCULAR HYPERAEMIA 5 0.0001
779 EXPOSURE DURING PREGNANCY 7 0.0001
780 GASTRIC DISORDER 5 0.0001
781 GAIT DISTURBANCE 23 0.0001
782 COLITIS 4 0.0001
783 INTENTIONAL OVERDOSE 7 0.0001
784 RASH PRURITIC 6 0.0001
785 STAPHYLOCOCCAL INFECTION 4 0.0001
786 SENSORY DISTURBANCE 2 0.0001
787 PRODUCTIVE COUGH 5 0.0001
788 STRESS 8 0.0001
789 MOBILITY DECREASED 8 0.0001
790 PROCEDURAL PAIN 3 0.0001
791 APPENDICITIS 1 0.0001
792 PHOTOPHOBIA 2 0.0001
793 NEOPLASM PROGRESSION 4 0.0001
794 BALANCE DISORDER 10 0.0001
795 ORTHOSTATIC HYPOTENSION 2 0.0001
796 VERTIGO 7 0.0001
797 BLISTER 6 0.0001
798 OVERDOSE 24 0.0001
799 HEMIPARESIS 2 0.0001
800 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
801 ACUTE RESPIRATORY FAILURE 2 0.0001
802 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
803 CIRCULATORY COLLAPSE 2 0.0001
804 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
805 EYE SWELLING 4 0.0001
806 DEHYDRATION 15 0.0001
807 THROAT TIGHTNESS 3 0.0001
808 ANURIA 1 0.0001
809 FALL 36 0.0001
810 ABDOMINAL PAIN 25 0.0001
811 ATRIAL SEPTAL DEFECT 1 0.0001
812 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
813 DEVICE LEAKAGE 3 0.0001
814 INJECTION SITE HAEMORRHAGE 8 0.0001
815 LUNG DISORDER 5 0.0001
816 BLOOD SODIUM DECREASED 2 0.0001
817 MENTAL STATUS CHANGES 3 0.0001
818 THERAPEUTIC RESPONSE DECREASED 6 0.0001
819 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
820 INFLUENZA LIKE ILLNESS 9 0.0001
821 GLAUCOMA 2 0.0001
822 MENSTRUATION IRREGULAR 3 0.0001
823 BACK PAIN 24 0.0001
824 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
825 POST PROCEDURAL COMPLICATION 2 0.0001
826 ADRENAL INSUFFICIENCY 1 0.0001
827 BONE DISORDER 2 0.0001
828 ABORTION INDUCED 1 0.0001
829 DIABETES MELLITUS 8 0.0001
830 DYSSTASIA 3 0.0001
831 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
832 ABASIA 3 0.0001
833 DEEP VEIN THROMBOSIS 7 0.0001
834 MOUTH ULCERATION 2 0.0001
835 RIB FRACTURE 2 0.0001
836 OXYGEN SATURATION DECREASED 5 0.0001
837 RASH ERYTHEMATOUS 4 0.0001
838 CELLULITIS 5 0.0001
839 ASPIRATION 1 0.0001
840 ABORTION SPONTANEOUS 4 0.0001
841 METRORRHAGIA 2 0.0001
842 RHABDOMYOLYSIS 4 0.0001
843 INFECTION 13 0.0001
844 IMPAIRED HEALING 3 0.0001
845 DRUG HYPERSENSITIVITY 19 0.0001
846 INJECTION SITE PAIN 26 0.0001
847 RASH MACULO-PAPULAR 2 0.0001
848 EYE DISORDER 3 0.0001
849 DRUG INTERACTION 15 0.0001
850 HEPATIC ENZYME INCREASED 6 0.0001
851 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
852 LIVER FUNCTION TEST ABNORMAL 3 0.0001
853 PRURITUS 31 0.0001
854 THROAT IRRITATION 4 0.0001
855 FLUSHING 10 0.0001
856 PANCREATITIS ACUTE 2 0.0001
857 NASAL CONGESTION 5 0.0001
858 DEVICE DISLOCATION 4 0.0001
859 URINARY RETENTION 3 0.0001
860 BACTERAEMIA 1 0.0001
861 TOOTH LOSS 2 0.0001
862 CYSTITIS 3 0.0001
863 TYPE 2 DIABETES MELLITUS 3 0.0001
864 CHOLELITHIASIS 3 0.0001
865 PREGNANCY 2 0.0001
866 PSORIATIC ARTHROPATHY 3 0.0001
867 PERICARDIAL EFFUSION 2 0.0001
868 ARTHRALGIA 35 0.0001
869 ADVERSE EVENT 8 0.0001
870 COVID-19 13 0.0001
871 INJECTION SITE MASS 3 0.0001
872 INTESTINAL OBSTRUCTION 3 0.0001
873 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
874 DEVICE MALFUNCTION 5 0.0001
875 RASH PAPULAR 2 0.0001
876 CHILLS 10 0.0001
877 RESPIRATORY TRACT INFECTION 2 0.0001
878 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
879 PAIN IN EXTREMITY 25 0.0001
880 MYALGIA 14 0.0001
881 HOSPITALISATION 11 0.0001
882 EYE PAIN 4 0.0001
883 HYPERGLYCAEMIA 3 0.0001
884 MULTIPLE SCLEROSIS 4 0.0001
885 MUSCULOSKELETAL STIFFNESS 7 0.0001
886 ERECTILE DYSFUNCTION 2 0.0001
887 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
888 BLOOD GLUCOSE DECREASED 4 0.0001
889 ACUTE HEPATIC FAILURE 1 0.0001
890 LIMB INJURY 2 0.0001
891 PNEUMONIA 24 0.0001
892 ARTHRITIS 6 0.0001
893 OEDEMA PERIPHERAL 10 0.0001
894 SKIN ULCER 2 0.0001
895 ADVERSE REACTION 1 0.0001
896 THERAPY INTERRUPTED 3 0.0001
897 SKIN LESION 2 0.0001
898 JOINT STIFFNESS 2 0.0001
899 APHONIA 1 0.0001
900 GASTRITIS 2 0.0001
901 HYPOACUSIS 3 0.0001
902 PANCREATITIS 4 0.0001
903 DISCOMFORT 4 0.0001
904 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
905 INJECTION SITE REACTION 5 0.0001
906 EYE PRURITUS 2 0.0001
907 HOT FLUSH 5 0.0001
908 ARTHROPATHY 4 0.0001
909 RED BLOOD CELL COUNT DECREASED 2 0.0001
910 JAUNDICE 2 0.0001
911 DIARRHOEA 42 0.0001
912 PAIN IN JAW 2 0.0001
913 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
914 URINARY TRACT INFECTION 11 0.0001
915 HYPOKALAEMIA 3 0.0001
916 PLATELET COUNT DECREASED 7 0.0001
917 RESPIRATORY ARREST 2 0.0001
918 TINNITUS 3 0.0001
919 ANGINA PECTORIS 2 0.0001
920 BASAL CELL CARCINOMA 1 0.0001
921 HYPOTENSION 13 0.0001
922 APHASIA 2 0.0001
923 PREMATURE BABY 2 0.0001
924 RENAL DISORDER 3 0.0001
925 ACUTE MYOCARDIAL INFARCTION 2 0.0001
926 RHEUMATOID ARTHRITIS 7 0.0001
927 ABSCESS 1 0.0001
928 INFLAMMATION 3 0.0001
929 DYSGEUSIA 5 0.0001
930 SKIN DISORDER 2 0.0001
931 DYSPEPSIA 6 0.0001
932 CARDIAC DISORDER 6 0.0001
933 COMA 3 0.0001
934 PSORIASIS 8 0.0001
935 ARRHYTHMIA 3 0.0001
936 DELIRIUM 2 0.0001
937 CHRONIC KIDNEY DISEASE 5 0.0001
938 CARDIAC ARREST 5 0.0001
939 CORONARY ARTERY DISEASE 2 0.0001
940 BONE DENSITY DECREASED 2 0.0001
941 BACTERIAL INFECTION 1 0.0001
942 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
943 BLOOD GLUCOSE INCREASED 11 0.0001
944 BURNING SENSATION 4 0.0001
945 SWELLING 5 0.0001
946 ALOPECIA 11 0.0001
947 COLITIS ULCERATIVE 2 0.0001
948 FLATULENCE 3 0.0001
949 DRUG DEPENDENCE 10 0.0001
950 HERPES ZOSTER 3 0.0001
951 PRODUCT STORAGE ERROR 3 0.0001
952 PULMONARY EMBOLISM 5 0.0001
953 ALTERED STATE OF CONSCIOUSNESS 1 0.0001
954 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
955 DEVICE DIFFICULT TO USE 2 0.0001
956 LIVER DISORDER 2 0.0001
957 DISEASE PROGRESSION 5 0.0001
958 RECTAL HAEMORRHAGE 2 0.0001
959 CEREBROVASCULAR ACCIDENT 8 0.0001
960 VAGINAL HAEMORRHAGE 2 0.0001
961 JOINT SWELLING 5 0.0001
962 INJECTION SITE SWELLING 3 0.0001
963 DEVICE EXPULSION 3 0.0001
964 ANAPHYLACTIC SHOCK 1 0.0001
965 PERIPHERAL SWELLING 6 0.0001
966 MYOCARDIAL INFARCTION 8 0.0001
967 LEUKOPENIA 2 0.0001
968 ATRIAL FIBRILLATION 4 0.0001
969 HYPOGLYCAEMIA 2 0.0000
970 AGEUSIA 1 0.0000
971 HAEMORRHAGE 4 0.0000
972 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
973 FLUID RETENTION 2 0.0000
974 ABDOMINAL PAIN LOWER 1 0.0000
975 HAEMOGLOBIN DECREASED 4 0.0000
976 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
977 OEDEMA 2 0.0000
978 THROMBOSIS 3 0.0000
979 ANAEMIA 7 0.0000
980 CATARACT 2 0.0000
981 DRUG ABUSE 3 0.0000
982 HYPONATRAEMIA 2 0.0000
983 RENAL FAILURE 5 0.0000
984 MUSCULOSKELETAL PAIN 2 0.0000
985 NEUROPATHY PERIPHERAL 3 0.0000
986 BONE PAIN 2 0.0000
987 COMPLETED SUICIDE 3 0.0000
988 RESPIRATORY FAILURE 2 0.0000
989 CARDIAC FAILURE 2 0.0000
990 RENAL IMPAIRMENT 2 0.0000
991 ANGIOEDEMA 1 0.0000
992 ACUTE KIDNEY INJURY 3 0.0000
993 THROMBOCYTOPENIA 2 0.0000
994 INJECTION SITE ERYTHEMA 2 0.0000
995 NEUTROPENIA 2 0.0000
996 DEATH 11 0.0000